全球内窥镜可视化系统市场size was valued at USD 21.5 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.0% from 2021 to 2028. Endoscopy is a minimally invasive procedure used for the examination of the internal organs in the body. Visualization systems with advanced technologies can provide superior image quality, which makes them very important in the medical field. In recent years, endoscopic procedures have emerged as a potential adjunctive tool in various medical specialties such as general surgery, gastrointestinal, urology, and others. According to the Centers for Disease Control and Prevention, around 494,000 hysterectomies are performed in the U.S. annually. Approximately 80.0% of the surgeries are done laparoscopically or robotically. Thus, shift towards minimally invasive surgeries and increasing prevalence of cancer, thereby fueling the market growth.
The rising prevalence of diseases including colorectal cancer, gastrointestinal disorders, pancreatic abnormalities, urological, gynecological, and respiratory problems is expected to fuel the growth of the market. As per the World Cancer Research Fund, colorectal cancer is the 3rdmost common cancer in men and 2nd女性最常见的癌症。此外,雅高集团ding to the WHO, the number of new colon cancer cases is projected to increase from 1.15 million in 2020 to 1.51 million by 2030. This is anticipated to favor the demand for endoscopy procedures in the coming years. Apart from this, the increasing geriatric population adds to the patient population requiring endoscopic procedures. As per the estimate of the United Nations, the number of people aged 65 years and above is expected to reach from 703 million in 2019 to 1.5 billion by 2050. This is projected to drive the market for endoscopy visualization systems over the forecast period.
奥维内窥镜手术提供各种优势r open invasive surgeries. These procedures are associated with reduced recovery time, reduced hospital stay, less complication, lower cost, and smaller incisions resulting in better clinical outcomes. Owing to this, the adoption of minimally invasive endoscopy is increasing. According to an article published in the Gastrointestinal Endoscopy, an official publication of the American Society for Gastrointestinal Endoscopy, over 17.7 million endoscopic procedures are performed in the U.S. annually. This accounts for 5.6% of the U.S. population. Thus, a significant increase in the number of minimally invasive endoscopic procedures coupled with the rising cost burden of cancer is anticipated to favor the growth of the market for endoscopy visualization systems. Furthermore, active government support to promote less invasive surgeries in outpatient settings is likely to propel the growth of the market.
The COVID-19 pandemic has caused serious disruption in the healthcare industry. The pandemic has led to a decline in sales of medical devices globally. The cancellation or postponement of elective and non-urgent endoscopic procedures has negatively impacted the market for endoscopy visualization systems. For instance, as per a study published in PubMed on the impact of COVID-19 on gastrointestinal endoscopy in France, over 98.7% of the gastroenterologists had to cancel the endoscopic procedures in March 2020. In April 2020, the American College of Gastroenterology announced the suspension of elective endoscopy. Furthermore, the Canadian Association of Gastroenterology (CAG) also issued guidelines to be followed by hospitals providing endoscopy services. Strict protocols imposed on endoscopy facilities are expected to further decrease the surgery volume. Manufacturers, vendors, distributors operating in the market continue to get affected by the pandemic owing to the restrictive government measures. Apart from this, various government-organized cancer screening programs and initiatives were interrupted or canceled. However, the pandemic has increased the focus on single-use endoscopes as they provide for better infection control.
COVID-19 Impact |
Beyond COVID-19 |
The endoscopy visualization systems market decreased by 4.5% from 2019 to 2020 |
The market is estimated to witness a y-o-y growth of approximately 6% to 7% in the next 5 years |
The key factors for this decline are the supply chain disruptions and delay or cancellation in the non-emergency or elective surgical procedures. |
Endoscopy visualization systems as well as components are likely to grow at a substantial rate after the pandemic owing to normalization of regulations and re-initiation of elective procedures in many countries |
As per a study published in PubMed on the impact of COVID-19 on gastrointestinal endoscopy in France, over 98.7% of the gastroenterologists had to cancel the endoscopic procedures in March 2020. |
Increasing strategic initiatives in the form of mergers and acquisitions, collaborations and product launches will help in increasing the market shares of key players. |
The key players are now focusing on mergers and acquisitions and new product launches to sustain their business and accelerate the company’s growth. For instance, in January 2021, Olympus Corporation announced the acquisition of Quest Photonic Devices. This is expected to strengthen its position in the surgical endoscopy market and provide new growth opportunities to the company.
In 2020, the endoscopic visualization systems segment accounted for the largest revenue share of 71.5%. This can be attributed to technological advancements to enhance imaging capabilities. Key players such as Olympus Corporation, FUJIFILM Holdings Corporation, Boston Scientific, and others are focusing on introducing next-generation endoscopy visualization systems, which, in turn, is positively impacting the segment’s growth. For instance, in July 2020, Fujifilm Corporation launched ELUXEO Surgical System that provides excellent visualization while performing both rigid and flexible from a single tower.
Endoscopy visualization components include camera heads, lights sources, video processors, suction pumps, high definition monitors, insufflators, and others. The rising geriatric population and the growing number of endoscopic procedures are key factors responsible for the expansion of the segment. As per the estimates of the WHO, the estimated number of new gastric cancer cases is projected to reach 1.4 million by 2030. This is likely to augment the segment’s growth. In addition, increasing R&D investment by manufacturers for introducing advanced visualization components is projected to foster the growth of the segment.
In terms of resolution type, the 4K segment dominated the market for endoscopy visualization systems and held the largest revenue share of 59.8% in 2020. The segment is projected to witness substantial growth over the forecast period. When compared to full HD resolution, images with 4K resolution have a superior degree of color reproducibility allowing for more surgical accuracy and easier identification of the boundaries between nerves, lymph, blood vessels, and others. Furthermore, monitors with a 4K resolution can be viewed at a much closer distance without spotting the individual pixels. These advantages of 4K are fueling the growth of the segment.
However, the 4K monitors are most costly when compared to those with full HD resolution. Thus, FHD resolution provides a cost-effective alternative especially in developing economies. This combined with the easy availability of the products and rising awareness among the patient population is contributing to the expansion of the segment.
North America dominated the endoscopy visualization systems market and accounted for the largest revenue share of 43.3% in 2020. The rapid adoption of minimally invasive procedures, high prevalence of gastric and colorectal cancer, and growing demand for advanced diagnostic tools are factors attributable to the dominant share of the region in the market. According to the American Cancer Society, 104,270 new colon cancer and 45,230 new rectal cancer cases are expected to be diagnosed in the U.S. in 2021. Rising cases of cancer and favorable reimbursement policies are expected to fuel the market for endoscopy visualization systems in the region.
On the other hand, Asia Pacific is projected to witness remarkable growth over the forecast period owing to the high presence of age population in Asian countries such as China, India, and others. Furthermore, the strategic presence of key players such as Olympus Corporation, FUJIFILM Holdings Corporation, and Hoya Corporation is expected to favor market growth. As per the estimates of Olympus Corporation, there are 22 endoscopists per million population in China and 17 in Malaysia, 5 in India, and 6 in Vietnam. Thus, a rising number of endoscopists in developing economies is expected to boost the market for endoscopy visualization systems in the region.
In Europe, the market is poised to surge owing to the rising cost burden of cancer and the growing number of endoscopic procedures. According to Eurostat, the number of laparoscopic hysterectomies accounted for 53.6 per 100,000 inhabitants in Germany and 24.2 in the U.K. in 2018. This is anticipated to boost the market in Europe. Improving healthcare infrastructure and rising awareness among the patient population are expected to drive the market for endoscopy visualization systems in the Middle East and Africa and Latin America.
Olympus Corporation is estimated to hold a leading position in the market for endoscopy visualization systems in 2020. Strong distribution network, geographical footprints in key markets, and continuous focus on product innovation are factors rendering a prominent position to the company in the global market. Some of the prominent players in the endoscopy visualization systems market include:
Stryker Corporation
Boston Scientific Corporation
Ethicon US, LLC
Richard Wolf GmbH
Medtronic
Smith & Nephew plc
CONMED Corporation
Machida Endoscope Co., Ltd.
Pentax Medical
FUJIFILM Holdings Corporation
Karl Storz GmbH & Co. KG.
Olympus Corporation
Report Attribute |
Details |
Market size value in 2021 |
USD 21.8 billion |
Revenue forecast in 2028 |
USD 35.0 billion |
Growth Rate |
CAGR of 7.0% from 2021 to 2028 |
Base year for estimation |
2020 |
Historical data |
2014 - 2019 |
Forecast period |
2021 - 2028 |
Quantitative units |
Revenue in USD million and CAGR from 2021 to 2028 |
Report coverage |
Revenue, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product type, resolution type, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope |
U.S.; Canada; U.K.; Germany; Spain; France; Italy; Russia; Switzerland; Denmark; China; Japan; India; South Korea; Singapore; Australia; New Zealand; Thailand, Indonesia; Malaysia; Vietnam; Philippines; Brazil; Mexico; Argentina; Saudi Arabia; South Africa; UAE; Kuwait; Israel; Qatar |
Key companies profiled |
Olympus Corporation; Stryker Corporation; Boston Scientific Corporation; Ethicon US, LLC; Richard Wolf GmbH; Medtronic; Smith & Nephew plc; CONMED Corporation; Machida Endoscope Co., Ltd.; Pentax Medical; FUJIFILM Holdings Corporation; Karl Storz GmbH & Co. KG |
Customization scope |
Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
价格和购买该俱乐部ns |
Avail customized purchase options to meet your exact research needs.Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2028. For the purpose of this study, Grand View Research, Inc. has segmented the global endoscopy visualization systems market report on the basis of product type, resolution type, and region:
Product Type Outlook (Revenue, USDMillion, 2014 - 2028)
Endoscopic Visualization Systems
Standard Definition (SD) Visualization Systems
2D Systems
3D Systems
High Definition (HD) Visualization Systems
2D Systems
3D Systems
Endoscopy Visualization Components
Camera Heads
Insufflators
Light Sources
High Definition Monitors
Suction Pumps
Video Processors
Resolution Type Outlook (Revenue, USD Million, 2014 - 2028)
4K
UHD Resolution
DCI resolution
FHD Resolution
Regional Outlook (Revenue, USD Million, 2014 - 2028)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Russia
Switzerland
Denmark
Asia Pacific
Japan
China
India
Australia
New Zealand
Thailand
Indonesia
Malaysia
Vietnam
Philippines
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Saudi Arabia
South Africa
UAE
Kuwait
Israel
Qatar
b.In 2020, the endoscopic visualization systems segment in the endoscopy visualization systems market accounted for the largest revenue share of 71.5%.
b.In terms of resolution type, the 4K segment dominated the market for endoscopy visualization systems and held the largest revenue share of 59.8% in 2020.
b.全球内窥镜可视化系统市场size was estimated at USD 21.5 billion in 2020 and is expected to reach USD 21.8 billion in 2021.
b.全球内窥镜可视化系统市场is expected to grow at a compound annual growth rate of 7.0% from 2021 to 2028 to reach USD 35.0 billion by 2028.
b.North America dominated the endoscopy visualization systems market with a share of 43.3% in 2020. This is attributable to improved healthcare infrastructure, high adoption of advanced technologies, and increased preference for minimally invasive surgeries to curb healthcare spending.
b.Some key players operating in the endoscopy visualization systems market include Olympus Corporation; Ethicon Endo-Surgery, LLC; Stryker Corporation; PENTAX Medical; Boston Scientific Corporation; Fujifilm Holdings Corporation; Machida Endoscope Co., Ltd.; Richard Wolf GmbH; Smith & Nephew, Inc.; and Karl Storz.
b.Key factors that are driving the endoscopy visualization systems market growth include an increase in the geriatric population with long-term medical conditions & subsequent rise in the prevalence of chronic diseases, technological advancements, and a rise in the preference for minimally invasive surgeries.
"The quality of research they have done for us has been excellent."